Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Politics : Formerly About Advanced Micro Devices -- Ignore unavailable to you. Want to Upgrade?

To: pocotrader who wrote (1300248)	5/12/2021 4:21:16 PM
From: Bonefish	Read Replies (1) \| Respond to of 1579880

Laws were broken. Is that fraud?

To: pocotrader who wrote (1300248)	5/12/2021 4:23:58 PM
From: pocotrader	Respond to of 1579880

The Latest: US endorses Pfizer COVID shot for kids 12 and up 32 minutes ago NEW YORK—U.S. health advisers have endorsed use of Pfizer’s COVID-19 vaccine in kids as young as 12. The Food and Drug Administration earlier in the week cleared the expanded use of Pfizer’s shots, citing evidence the shots worked as well in those 12 to 15 years old as those 16 and older. Kids in some places are already rolling up their sleeves. But much of the nation was waiting for Wednesday’s recommendations from advisers to the Centers for Disease Control and Prevention. Many states will be shipping doses to pediatricians and even to schools. Pfizer is not the only company seeking to lower the age limit for its vaccine. Moderna recently said preliminary results from its study in 12- to 17-year-olds show strong protection and no serious side effects, data the FDA will need to scrutinize. ca.finance.yahoo.com